Literature DB >> 2758239

Effects of propafenone on electrical and mechanical activities of single ventricular myocytes isolated from guinea-pig hearts.

H Honjo1, T Watanabe, K Kamiya, I Kodama, J Toyama.   

Abstract

1. The effects of propafenone on the transmembrane action potential and sarcomere shortening during twitch contraction were investigated in single ventricular myocytes isolated from guinea-pig hearts. 2. Propafenone at low concentrations (3-5 x 10(-7) M) slightly lengthened action potential duration (APD), but shortened it at higher concentrations. The shortening of APD was accompanied by an attenuation of sarcomere shortening during twitch contraction. 3. Propafenone (greater than 10(-6) M) caused a concentration-dependent decrease in the maximum upstroke velocity (Vmax) of the action potential. In the presence of propafenone (3 x 10(-6) M), trains of stimuli led to an exponential decline in Vmax. A time constant for the recovery of Vmax from the use-dependent block was 4.8 s. 4. In myocytes treated with propafenone (3 x 10(-6) M), the Vmax of test action potentials preceded by the conditioning clamp pulses to 0 mV was progressively decreased by increasing the duration of single clamp pulse or by increasing the number of multiple brief clamp pulses. 5. These findings suggest that propafenone has use-dependent inhibitory action on the sodium channel by binding to the channel during both activated and inactivated states, and that the unbinding rate is comparable to that of Class-I antiarrhythmic drugs with intermediate kinetics. Propafenone may also have an inhibitory action on calcium and potassium channels.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2758239      PMCID: PMC1854590          DOI: 10.1111/j.1476-5381.1989.tb12010.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  20 in total

Review 1.  Time- and voltage-dependent interactions of antiarrhythmic drugs with cardiac sodium channels.

Authors:  L M Hondeghem; B G Katzung
Journal:  Biochim Biophys Acta       Date:  1977-11-14

2.  The multiple modes of action of propafenone.

Authors:  I D Dukes; E M Vaughan Williams
Journal:  Eur Heart J       Date:  1984-02       Impact factor: 29.983

3.  Inhibition of Vmax of the action potential by propafenone and its voltage-, time- and pH-dependence in mammalian ventricular myocardium.

Authors:  M Kohlhardt; C Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980       Impact factor: 3.000

4.  Why do some drugs preferentially block open sodium channels?

Authors:  K R Courtney
Journal:  J Mol Cell Cardiol       Date:  1988-06       Impact factor: 5.000

5.  Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches.

Authors:  O P Hamill; A Marty; E Neher; B Sakmann; F J Sigworth
Journal:  Pflugers Arch       Date:  1981-08       Impact factor: 3.657

6.  Tonic and phasic INa blockade by antiarrhythmics. Different properties of drug binding to fast sodium channels as judged from Vmax studies with propafenone and derivatives in mammalian ventricular myocardium.

Authors:  M Kohlhardt; C Seifert; L M Hondeghem
Journal:  Pflugers Arch       Date:  1983-03-01       Impact factor: 3.657

7.  Kinetics of onset of rate-dependent effects of Class I antiarrhythmic drugs are important in determining their effects on refractoriness in guinea-pig ventricle, and provide a theoretical basis for their subclassification.

Authors:  T J Campbell
Journal:  Cardiovasc Res       Date:  1983-06       Impact factor: 10.787

Review 8.  Propafenone--a new antiarrhythmic drug.

Authors:  L Seipel; G Breithardt
Journal:  Eur Heart J       Date:  1980-08       Impact factor: 29.983

9.  Electrophysiological and antiarrhythmic properties of propafenon in isolated cardiac preparations.

Authors:  F Ledda; L Mantelli; S Manzini; S Amerini; A Mugelli
Journal:  J Cardiovasc Pharmacol       Date:  1981 Nov-Dec       Impact factor: 3.105

10.  Clinical efficacy and electrophysiology of oral propafenone for ventricular tachycardia.

Authors:  S J Connolly; R E Kates; C S Lebsack; D S Echt; J W Mason; R A Winkle
Journal:  Am J Cardiol       Date:  1983-12-01       Impact factor: 2.778

View more
  8 in total

1.  Electrophysiological effects of diprafenone, a dimethyl congener of propafenone on guinea-pig ventricular cells.

Authors:  I Kodama; R Suzuki; H Honjo; J Toyama
Journal:  Br J Pharmacol       Date:  1992-11       Impact factor: 8.739

Review 2.  Antiarrhythmic drug classifications. A critical appraisal of their history, present status, and clinical relevance.

Authors:  S Nattel
Journal:  Drugs       Date:  1991-05       Impact factor: 9.546

3.  Ryanodine receptor inhibition potentiates the activity of Na channel blockers against spontaneous calcium elevations and delayed afterdepolarizations in Langendorff-perfused rabbit ventricles.

Authors:  Young Soo Lee; Mitsunori Maruyama; Po Cheng Chang; Hyung Wook Park; Kyoung-Suk Rhee; Yu-Cheng Hsieh; Chia-Hsiang Hsueh; Changyu Shen; Shien-Fong Lin; Hyun Seok Hwang; Huiyong Yin; Björn C Knollmann; Peng-Sheng Chen
Journal:  Heart Rhythm       Date:  2012-03-01       Impact factor: 6.343

Review 4.  Propafenone. A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in cardiac arrhythmias.

Authors:  H M Bryson; K J Palmer; H D Langtry; A Fitton
Journal:  Drugs       Date:  1993-01       Impact factor: 9.546

5.  Electrophysiological effects of Ro 22-9194, a new antiarrhythmic agent, on guinea-pig ventricular cells.

Authors:  K Maruyama; I Kodama; T Anno; R Suzuki; J Toyama
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

6.  Effects of propafenone on calcium currents in single ventricular myocytes of guinea-pig.

Authors:  L Fei; J S Gill; W J McKenna; A J Camm
Journal:  Br J Pharmacol       Date:  1993-05       Impact factor: 8.739

7.  Effects of propafenone on calcium current in guinea-pig ventricular myocytes.

Authors:  C Delgado; J Tamargo; D Henzel; P Lorente
Journal:  Br J Pharmacol       Date:  1993-03       Impact factor: 8.739

8.  Antiarrhythmic agents act differently on the activation phase of the ACh-response in guinea-pig atrial myocytes.

Authors:  N Inomata; T Ohno; T Ishihara; N Akaike
Journal:  Br J Pharmacol       Date:  1993-01       Impact factor: 8.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.